Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Efficacy and Safety Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled SPROUT Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s254, 2023. DOI: 10.25251/skin.7.supp.254. Disponível em: https://skin.dermsquared.com/skin/article/view/2441. Acesso em: 19 apr. 2025.